Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

HHS Logo Eagle IconU.S. Department of Health and Human Services

Office of Science and Data Policy (SDP)

The Office of Science and Data Policy is the departmental focal point for policy research, analysis, evaluation, and coordination of department-wide public health science policy and data policy activities and issues. The Office provides authoritative advice and analytical support to the ASPE and departmental leadership on public health science policy and data policy issues and initiatives, coordinates science and data policy issues of interagency scope within HHS, and manages interagency initiatives in science policy and data policy. The Office works closely with staff from across the Department on strategic plan development and implementation efforts. The Offices also carries out a program of policy research, analysis, evaluation, and data development in these issues.

The Office of Science and Data Policy includes several components:

Topic Areas:

  • HHS Data Council
  • Regulatory Impact Analysis
  • Strategic Planning
  • Information Quality Guidelines
  • Prevention and wellness
  • Public health systems and functions
  • Food safety and nutrition
  • Drugs and devices
  • Tobacco control and prevention
  • Biomedical research and development
  • Economic analysis
  • Emergency preparedness, response, and recovery
  • Data and statistical policy
  • Health disparities and vulnerable populations
  • Health information technology
  • Microsimulation
  • Privacy policy

Reports

Displaying 11 - 20 of 136. 10 per page. Page 2.

Advanced Search
ASPE Issue Brief, Database, Dataset

Flexibilities in Controlled Substances Prescribing and Dispensing During the COVID-19 Pandemic

September 8, 2022
The COVID-19 pandemic had wide-ranging impacts on health care delivery, particularly services that require in-person interactions. For patients needing access to medications to treat pain or certain substance use disorders, the COVID-19 pandemic presented particular challenges for continuity of treatment.
Report

Understanding Coverage Considerations for COVID-19 Vaccines and Treatments

August 31, 2022
COVID-19 vaccines and treatments have been an important tool in the prevention of COVID-19, including preventing hospitalizations and deaths.
Report

Opportunities to Improve Data Interoperability and Integration to Support Value-Based Care

July 27, 2022
In value-based models of health care delivery, providers are financially rewarded or penalized on the basis of the quality of care they provide to patients, typically measured by patient outcomes.
Report

National Action Plan for Combating Antibiotic-Resistant Bacteria Progress Report: Year 5

May 13, 2022
The National Action Plan for Combating Antibiotic-Resistant Bacteria 2015 – 2020 (2015 Plan) has guided the U.S. Government’s response to combating antibiotic-resistant infections since its establishment in 2015. The U.S. Government’s Interagency Task Force for Combating Antibiotic-Resistant Bacteria (CARB) has produced four previous reports on progress toward the 2015 Plan.
ASPE Issue Brief

Quality of Federal COVID-19 Data

April 12, 2022
This analysis applies the Federal Committee on Statistical Methodology's Data Quality Framework to assess the data quality of federal data for understanding and responding to the COVID-19 pandemic, focusing on five COVID-19 indicators: testing, cases, hospitalizations, deaths, and vaccinations.
ASPE Issue Brief

Trends in COVID-19 Vaccination Intentions

April 5, 2022
We document a number of key facts related to trends in COVID-19 vaccination intentions of unvaccinated adults in the United States from April 2021 to January 2022 using the Household Pulse Survey. First, among unvaccinated adults both those who were willing to vaccinate and those who were previously unwilling to vaccinate eventually vaccinated in large numbers.
Report

FY 2023 HHS Evaluation Plan

March 28, 2022
This Annual Evaluation Plan is one of several required Evidence Act products, including the 4-year Evidence-Building Plan (also referred to as the Learning Agenda), Capacity Assessment, and agency Evaluation Policy. The FY2023 Evaluation Plan priority areas are aligned with the goals of the FY 2022-2026 HHS Strategic Plan and the FY 2023- 2026 HHS Evidence-Building Plan.
Report

FY 2023-2026 HHS Capacity Assessment

March 28, 2022
Under the Foundations for Evidence-Based Policymaking Act of 2018 (Evidence Act), the Capacity Assessment requires agencies to assess the coverage, quality, methods, effectiveness, and independence of their statistics, evaluation, research, and analysis efforts.
Report

FY 2023-2026 HHS Evidence-Building Plan

March 28, 2022
The HHS Evidence Building Plan, required by the Evidence Act, is a systematic plan for identifying and addressing policy questions relevant to the programs, policies, and regulations of the agency.
ASPE Issue Brief

Demographic Characteristics of Adults Receiving COVID-19 Booster Vaccinations

March 18, 2022
This ASPE issue brief examines demographic characteristics of adults receiving booster doses of COVID-19 vaccines using data from the U.S. Census Bureau's Household Pulse Survey. As of March 9, 2022, 47.5 percent of the fully vaccinated adult population has received a booster.